Clinical and demographic characteristics of patients with deep vein thrombosis in a referral hospital in Paraguay during the COVID-19 pandemic (2020-2023)
DOI:
https://doi.org/10.53732/rccsalud/2024.e6152Keywords:
deep vein thrombosis, Covid-19, anticoagulants, low molecular weight heparin, risk factorsAbstract
Introduction. Venous thromboembolic disease, which includes deep vein thrombosis (DVT), is the third most common cardiovascular disease worldwide, with significant morbidity and mortality. Objective. To describe the clinical and demographic characteristics of patients with Deep Vein Thrombosis (DVT) admitted to a referral hospital in Paraguay during the COVID-19 pandemic (2020-2023). Materials and methods. Observational, descriptive, retrospective, cross-sectional study. 80 patients over 18 years of age with a confirmed diagnosis of DVT were included, selected by non-probabilistic sampling of consecutive cases. Demographic, clinical, and treatment data were collected from medical records. Results. The mean age was 52 ± 17 years, with a predominance of females (55%, 95% CI: 44-66%). COVID-19 disease was the most frequent underlying pathology (29%, 95% CI: 19-39%). According to the Wells scale, 62.5% (95% CI: 51-73%) presented moderate risk of DVT. Limb asymmetry (65%, 95% CI: 54-75%) and calf pain (61.25%, 95% CI: 50-72%) were the most frequent symptoms. 72.5% (95% CI: 62-82%) received low molecular weight heparin during hospitalization. Conclusion. DVT in this center predominantly affected middle-aged women, with COVID-19 as an emerging risk factor. These findings underline the need for active surveillance of DVT in patients with COVID-19 and suggest the importance of prevention and treatment strategies adapted to the pandemic context in Paraguay.
References
Sandino VM, Vega EV. Abordaje de trombosis venosa profunda en miembros inferiores. Revista Medica Sinergia. 2020;5(2):e360-e360. https://doi.org/10.31434/rms.v5i2.360
García Fajardo JD, Bolaño Vaillant S, Dosouto Infante V, Flores Ramírez I, Pascual Díaz JD, et al. Ecografía Doppler en el diagnóstico de trombosis venosa profunda de miembros inferiores. Multimed. 2020;24(6):1271-82. https://www.medigraphic.com/pdfs/multimed/mul-2020/mul206d.pdf
Muñoz Rodríguez FJ. Diagnóstico de la trombosis venosa profunda. Revista Clínica Española. 2020;220:41-9. https://doi.org/10.1016/j.rce.2020.03.009
García-Gómez MA, García-Pérez J, Colorado-Cruz MF, López-Burgos CP, López-Zamora B, León-Pérez KM, et al. Ethiology, risk factors and Whole blood viscosity index in thromboembolic venous disease. Rev Med Inst Mex Seguro Soc. 2023;61(2):140-6. https://pubmed.ncbi.nlm.nih.gov/37200530/
Áinle FN, Kevane B. Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)? Blood Adv. 2020;4(21):5595-606. https://doi.org/10.1182/bloodadvances.2020002268
Alonso-Beato R, Lago-Rodríguez MO, López-Rubio M, Gómez-Tórtola A, García-Fernández-Bravo I, Oblitas CM, et al. Risk of thrombosis recurrence among patients with COVID-19 and surgery-associated venous thromboembolism. Rev Clin Esp (Barc). 2023;223(5):255-61. https://doi.org/10.1016/j.rceng.2023.03.003
Bustillo Santandreu M de J, Álvarez López Y, Feíto Castex TR, García Seco F, Montes de Oca García Y, González Bustillo EA, et al. Morbi-mortalidad de la enfermedad tromboembólica venosa en el Hospital Universitario “Arnaldo Milián Castro”. Revista Cubana de Angiología y Cirugía Vascular. 2022;23(1). https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=113819
Marini CP, Lewis E, Petrone P, Zenilman A, Lu Z, Rivera A, et al. Incidence and effects of deep vein thrombosis on the outcome of patients with coronavirus disease 2019 infection. J Vasc Surg Venous Lymphat Disord. 2022;10(4):803-10. https://doi.org/10.1016/j.jvsv.2021.10.013
Cosmi B, Borgese L, Legnani C, Sartori M, Palareti G. Sex Differences in Clinical Presentation of Lower Extremity Deep Vein Thrombosis. J Women’s Health. 2024;33(6):758-64. https://doi.org/10.1089/jwh.2023.0450
Chan SM, Brahmandam A, Valcarce-Aspegren M, Zhuo H, Zhang Y, Tonnessen BH, et al. Sex differences in long-term outcomes of patients with deep vein thrombosis. Vascular. 2023;31(5):994-1002. https://doi.org/10.1177/17085381221097746
Wilcox T, Smilowitz NR, Seda B, Xia Y, Hochman J, Berger JS. Sex Differences in Thrombosis and Mortality in Patients Hospitalized for COVID-19. The American Journal of Cardiology. 2022;170:112-7. https://doi.org/10.1016/j.amjcard.2022.01.024
Saliba Júnior OA, Alves AFDJ, Matarazzo C, Gonçalves GT, Sobreira ML. Trombose venosa profunda de membros inferiores em pacientes com covid-19. J vasc bras. 2023;22:e20230027. https://doi.org/10.1590/1677-5449.202300271
Yamashita Y, Yachi S, Takeyama M, Nishimoto Y, Tsujino I, Nakamura J, et al. Significant Impact of Age on Mortality and Non-significant Impact of Age on Thrombosis and Major Bleeding in Patients with COVID-19: From the CLOT-COVID Study. J Atheroscler Thromb. 2023;30(6):624-35. https://doi.org/10.5551/jat.63702
Currey J, Ellsworth C, Khatun MS, Wang C, Chen Z, Liu S, et al. Upregulation of inflammatory genes and pathways links obesity to severe COVID-19. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2024;1870(7):167322. https://doi.org/10.1016/j.bbadis.2024.167322
Lobanova KG, Skuridina DV, Bairova VE. Pathophysiological aspects of the effect of obesity on the course of viral diseases. FOCUS. Endocrinology. 2024;5(2):46-51. https://doi.org/10.62751/2713-0177-2024-5-2-17
Mancuso P. Obesity and Respiratory Infections Including COVID-19. En: Dixon AE, Forno E, editores. Obesity and Lung Disease. Cham: Springer International Publishing; 2024. 301-20. Respiratory Medicine. https://link.springer.com/10.1007/978-3-031-52696-1_15
Reddy A, Savlania A, Naik A, Rastogi P, Gorsi U. Deep venous thrombosis manifestation of common femoral vein leiomyoma. annals. 2020;102(6):e141-4. https://doi.org/10.1308/rcsann.2020.0062
Baroncini LAV, Franca GJ, Oliveira AD, AntonioVidal E, Valle CED, Stahlke PSDB, et al. Correlation of clinical features with the risk of lower limb deep vein thrombosis assessed by duplex ultrasound. J vasc bras. 2013;12(2):118-22. https://doi.org/10.1590/S1677-54492013000200005
Link D. Late Complications of Deep Venous Thrombosis: Painful Swollen Extremities and Non Healing Ulcers. En: Okuyan E, editor. Venous Thrombosis - Principles and Practice. InTech; 2012. https://doi.org/10.5772/26726
Gibson K, Nicolini P. Up to Date Guidance for the Clinical Management of Chronic Venous Disease. Eur J Vasc Endovasc Surg. 2022;63(2):179-80. https://doi.org/10.1016/j.ejvs.2022.01.019
Rognoni C, Lugli M, Maleti O, Tarricone R. Clinical guidelines versus current clinical practice for the management of deep vein thrombosis. J Vasc Surg Venous Lymphatic Disord. 2021;9(5):1334-1344.e1. https://doi.org/10.1016/j.jvsv.2021.01.020
Kumar AH. Comparative Pharmacology of Direct Oral Anticoagulants and Vitamin K Antagonist. BEMS Reports. 2022;8(2):16-23. https://doi.org/10.5530/bems.8.2.5
.png)
All the contents of this journal are licensed under a 